Moreover, TNF-α inhibitors have been explored as adjunctive treatments in bipolar disorder, where infliximab showed benefits on depressive symptoms, cognitive function, and neuroinflammatory markers [45,46,47]. Here, TNF is linked to bipolar disorder.